Literature DB >> 7678597

Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor.

F C Martin1, P A Anton, J A Gornbein, F Shanahan, J E Merrill.   

Abstract

Substance P (SP) is a central and peripheral neurotransmitter which has been found in multiple sclerosis plaques. SP stimulates peripheral immune cells and may play a role in some chronic inflammatory diseases. Human peripheral monocyte/macrophages have been shown to produce the inflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF alpha) in response to SP. Therefore, in this study we examined rat brain microglia for the presence of SP receptors and production of IL-1 and TNF alpha in response to SP. Microglia had 4900 +/- 950 (mean +/- SE) receptors per cell fitting a two-site model. Four percent of these were high-affinity receptors with a Kd of 8.2 x 10(-8) M +/- 3.6 x 10(-8) M (mean +/- SE), and 96% of them were low-affinity receptors with a Kd of 2.1 x 10(-6) M +/- 5.2 x 10(-7) M (mean +/- SE). Competitive studies with CP 96,345 and other SP analogs demonstrate these to be non-classical NK-1 receptors. SP alone did not stimulate IL-1 or TNF alpha production. However, SP in synergy with lipopolysaccharide (LPS) quadrupled IL-1 production compared to LPS alone, but did not affect TNF alpha production. These results have implications for certain inflammatory conditions in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678597     DOI: 10.1016/0165-5728(93)90212-h

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice.

Authors:  Jing Wang; Jesus A Angulo
Journal:  Brain Res       Date:  2010-11-11       Impact factor: 3.252

Review 2.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 3.  Implications of immune-to-brain communication for sickness and pain.

Authors:  L R Watkins; S F Maier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 4.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

Review 5.  Vasculitis of the central nervous system.

Authors:  P M Moore
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

6.  Effects of microenvironment on morphology and function of the microglial cell line BV-2.

Authors:  M A Laurenzi; C Arcuri; R Rossi; P Marconi; V Bocchini
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

7.  Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.

Authors:  W-W Li; T-Z Guo; X Shi; Y Sun; T Wei; D J Clark; W S Kingery
Journal:  Neuroscience       Date:  2015-09-16       Impact factor: 3.590

8.  Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages.

Authors:  G F Zhu; C Chancellor-Freeland; A S Berman; R Kage; S E Leeman; D I Beller; P H Black
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

9.  Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats.

Authors:  Erin D Milligan; Carin Twining; Marucia Chacur; Joseph Biedenkapp; Kevin O'Connor; Stephen Poole; Kevin Tracey; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Substance P augments tumor necrosis factor release in human monocyte-derived macrophages.

Authors:  H R Lee; W Z Ho; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.